{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T14:00:17Z","timestamp":1773842417773,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T00:00:00Z","timestamp":1491177600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s12185-017-2226-0","type":"journal-article","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T10:53:07Z","timestamp":1491216787000},"page":"345-356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["DNA damage response and hematological malignancy"],"prefix":"10.1007","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7580-9184","authenticated-orcid":false,"given":"Masatoshi","family":"Takagi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,3]]},"reference":[{"key":"2226_CR1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrg2380","volume":"9","author":"KW Caldecott","year":"2008","unstructured":"Caldecott KW. Single-strand break repair and genetic disease. Nat Rev Genet. 2008;9:619\u201331.","journal-title":"Nat Rev Genet"},{"key":"2226_CR2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0968-0004(99)01413-9","volume":"24","author":"JE Haber","year":"1999","unstructured":"Haber JE. DNA recombination: the replication connection. Trends Biochem Sci. 1999;24:271\u20135.","journal-title":"Trends Biochem Sci"},{"key":"2226_CR3","doi-asserted-by":"crossref","first-page":"12871","DOI":"10.1073\/pnas.2135498100","volume":"100","author":"MM Vilenchik","year":"2003","unstructured":"Vilenchik MM, Knudson AG. Endogenous DNA double-strand breaks: production, fidelity of repair, and induction of cancer. Proc Natl Acad Sci USA. 2003;100:12871\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2226_CR4","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1093\/emboj\/cdg541","volume":"22","author":"T Uziel","year":"2003","unstructured":"Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L, Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 2003;22:5612\u201321.","journal-title":"EMBO J"},{"key":"2226_CR5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature01368","volume":"421","author":"CJ Bakkenist","year":"2003","unstructured":"Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 2003;421:499\u2013506.","journal-title":"Nature"},{"key":"2226_CR6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrc1011","volume":"3","author":"Y Shiloh","year":"2003","unstructured":"Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer. 2003;3:155\u201368.","journal-title":"Nat Rev Cancer"},{"key":"2226_CR7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0092-8674(92)90593-2","volume":"71","author":"MB Kastan","year":"1992","unstructured":"Kastan MB, Zhan Q, El-Deiry DW, Carrier F, Jacks T, Walsh WV, Plunkett BS, et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 1992;71:587\u201397.","journal-title":"Cell"},{"key":"2226_CR8","first-page":"5054","volume":"54","author":"CE Canman","year":"1994","unstructured":"Canman CE, Wolff AC, Chen CY, Fornace AJ, Kastan MB. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Cancer Res. 1994;54:5054\u20138.","journal-title":"Cancer Res"},{"key":"2226_CR9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1101\/gad.14.3.278","volume":"14","author":"NH Chehab","year":"2000","unstructured":"Chehab NH, Malikzay A, Appel M, Halazonetis TD. Chk2\/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev. 2000;14:278\u201388.","journal-title":"Genes Dev"},{"key":"2226_CR10","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1101\/gad.886901","volume":"15","author":"R Maya","year":"2001","unstructured":"Maya R, Balass M, Kim ST, Shkedy D, Leal JF, Shifman O, Moas M, et al. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 2001;15:1067\u201377.","journal-title":"Genes Dev"},{"key":"2226_CR11","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/35071124","volume":"410","author":"J Falck","year":"2001","unstructured":"Falck J, Mailand N, Syljuasen RG, Bartek J, Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature. 2001;410:842\u20137.","journal-title":"Nature"},{"key":"2226_CR12","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/nrm1493","volume":"5","author":"J Bartek","year":"2004","unstructured":"Bartek J, Lukas C, Lukas J. Checking on DNA damage in S phase. Nat Rev Mol Cell Biol. 2004;5:792\u2013804.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2226_CR13","doi-asserted-by":"crossref","first-page":"16139","DOI":"10.1074\/jbc.M113.456780","volume":"288","author":"B Qin","year":"2013","unstructured":"Qin B, Gao B, Yu J, Yuan J, Lou Z. Ataxia telangiectasia-mutated- and Rad3-related protein regulates the DNA damage-induced G2\/M checkpoint through the Aurora A cofactor Bora protein. J Biol Chem. 2013;288:16139\u201344.","journal-title":"J Biol Chem"},{"key":"2226_CR14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/embor.2011.99","volume":"12","author":"T Menzel","year":"2011","unstructured":"Menzel T, Nahse-Kumpf V, Kousholt AN, Klein DK, Lund-Andersen C, Lees M, Johansen JV, et al. A genetic screen identifies BRCA2 and PALB2 as key regulators of G2 checkpoint maintenance. EMBO Rep. 2011;12:705\u201312.","journal-title":"EMBO Rep"},{"key":"2226_CR15","first-page":"24","volume":"1786","author":"SJ Suijkerbuijk","year":"2008","unstructured":"Suijkerbuijk SJ, Kops GJ. Preventing aneuploidy: the contribution of mitotic checkpoint proteins. Biochim Biophys Acta. 2008;1786:24\u201331.","journal-title":"Biochim Biophys Acta"},{"key":"2226_CR16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.genet.37.042203.120656","volume":"37","author":"DJ Lew","year":"2003","unstructured":"Lew DJ, Burke DJ. The spindle assembly and spindle position checkpoints. Annu Rev Genet. 2003;37:251\u201382.","journal-title":"Annu Rev Genet"},{"key":"2226_CR17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.molcel.2011.09.016","volume":"44","author":"C Yang","year":"2011","unstructured":"Yang C, Tang X, Guo X, Niikura Y, Kitagawa K, Cui K, Wong ST, et al. Aurora-B mediated ATM serine 1403 phosphorylation is required for mitotic ATM activation and the spindle checkpoint. Mol Cell. 2011;44:597\u2013608.","journal-title":"Mol Cell"},{"key":"2226_CR18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1071-9091(03)00026-3","volume":"10","author":"S Perlman","year":"2003","unstructured":"Perlman S, Becker-Catania S, Gatti RA. Ataxia-telangiectasia: diagnosis and treatment. Semin Pediatr Neurol. 2003;10:173\u201382.","journal-title":"Semin Pediatr Neurol"},{"key":"2226_CR19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.radonc.2011.05.065","volume":"101","author":"NT Martin","year":"2011","unstructured":"Martin NT, Nahas SA, Tunuguntla R, Fike F, Gatti RA. Assessing \u2018radiosensitivity\u2019 with kinetic profiles of gamma-H2AX, 53BP1 and BRCA1 foci. Radiother Oncol. 2011;101:35\u20138.","journal-title":"Radiother Oncol"},{"key":"2226_CR20","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.1038\/sj.onc.1210876","volume":"26","author":"I Demuth","year":"2007","unstructured":"Demuth I, Digweed M. The clinical manifestation of a defective response to DNA double-strand breaks as exemplified by Nijmegen breakage syndrome. Oncogene. 2007;26:7792\u20138.","journal-title":"Oncogene"},{"key":"2226_CR21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cell.2005.07.034","volume":"123","author":"M Takagi","year":"2005","unstructured":"Takagi M, Absalon MJ, McLure KG, Kastan MB. Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell. 2005;123:49\u201363.","journal-title":"Cell"},{"key":"2226_CR22","doi-asserted-by":"crossref","first-page":"a000935","DOI":"10.1101\/cshperspect.a000935","volume":"2","author":"R Beckerman","year":"2010","unstructured":"Beckerman R, Prives C. Transcriptional regulation by p53. Cold Spring Harbor Perspect Biol. 2010;2:a000935.","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"2226_CR23","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/bjc.1997.593","volume":"76","author":"JM Appleby","year":"1997","unstructured":"Appleby JM, Barber JB, Levine E, Varley JM, Taylor AM, Stankovic T, Heighway J, et al. Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br J Cancer. 1997;76:1546\u20139.","journal-title":"Br J Cancer"},{"key":"2226_CR24","first-page":"1","volume":"150","author":"P Kleihues","year":"1997","unstructured":"Kleihues P, Schauble B, zur Hausen A, Esteve J, Ohgaki H. Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol. 1997;150:1\u201313.","journal-title":"Am J Pathol"},{"key":"2226_CR25","first-page":"83","volume":"10","author":"KE Nichols","year":"2001","unstructured":"Nichols KE, Malkin D, Garber JE, Fraumeni JF Jr, Li FP. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol Biomarkers Prev. 2001;10:83\u20137.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2226_CR26","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/ng.2532","volume":"45","author":"L Holmfeldt","year":"2013","unstructured":"Holmfeldt L, Wei L, Diaz-Flores E, Walsh M, Zhang J, Ding L, Payne-Turner D, et al. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet. 2013;45:242\u201352.","journal-title":"Nat Genet"},{"key":"2226_CR27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1399-0004.1989.tb02905.x","volume":"35","author":"J German","year":"1989","unstructured":"German J, Passarge E. Bloom\u2019s syndrome. XII. Report from the Registry for 1987. Clin Genet. 1989;35:57\u201369.","journal-title":"Clin Genet"},{"key":"2226_CR28","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.dnarep.2007.02.007","volume":"6","author":"L Wu","year":"2007","unstructured":"Wu L. Role of the BLM helicase in replication fork management. DNA Repair (Amst). 2007;6:936\u201344.","journal-title":"DNA Repair (Amst)"},{"key":"2226_CR29","volume-title":"GeneReviews(R)","author":"PA Mehta","year":"1993","unstructured":"Mehta PA, Tolar J. Fanconi anemia. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews(R). Seattle: University of Washington; 1993."},{"key":"2226_CR30","doi-asserted-by":"publisher","unstructured":"Mamrak NE, Shimamura A, Howlett NG. Recent discoveries in the molecular pathogenesis of the inherited bone marrow failure syndrome Fanconi anemia. Blood Rev. 2016. doi: 10.1016\/j.blre.2016.10.002 [Epub ahead of print].","DOI":"10.1016\/j.blre.2016.10.002"},{"key":"2226_CR31","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra012242","volume":"348","author":"HT Lynch","year":"2003","unstructured":"Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348:919\u201332.","journal-title":"N Engl J Med"},{"key":"2226_CR32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejmg.2015.12.014","volume":"59","author":"T Ripperger","year":"2016","unstructured":"Ripperger T, Schlegelberger B. Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome. Eur J Med Genet. 2016;59:133\u201342.","journal-title":"Eur J Med Genet"},{"key":"2226_CR33","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/jmedgenet-2015-103299","volume":"52","author":"N Lavoine","year":"2015","unstructured":"Lavoine N, Colas C, Muleris M, Bodo S, Duval A, Entz-Werle N, Coulet F, et al. Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort. J Med Genet. 2015;52:770\u20138.","journal-title":"J Med Genet"},{"key":"2226_CR34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ng0997-96","volume":"17","author":"I Vorechovsky","year":"1997","unstructured":"Vorechovsky I, Luo L, Dyer MJ, Catovsky D, Amlot PL, Yaxley JC, Foroni L, et al. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat Genet. 1997;17:96\u20139.","journal-title":"Nat Genet"},{"key":"2226_CR35","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood.V89.7.2516","volume":"89","author":"H Dohner","year":"1997","unstructured":"Dohner H, Stilgenbauer S, James MR, Benner A, Weilguni T, Bentz M, Fischer K, et al. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood. 1997;89:2516\u201322.","journal-title":"Blood"},{"key":"2226_CR36","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0140-6736(98)10117-4","volume":"353","author":"T Stankovic","year":"1999","unstructured":"Stankovic T, Weber P, Stewart G, Bedenham T, Murray J, Byrd PJ, Moss PA, et al. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet. 1999;353:26\u20139.","journal-title":"Lancet"},{"key":"2226_CR37","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1200\/JCO.2007.11.2649","volume":"25","author":"B Austen","year":"2007","unstructured":"Austen B, Skowronska A, Baker C, Powell JE, Gardiner A, Oscier D, Majid A, et al. Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion. J Clin Oncol. 2007;25:5448\u201357.","journal-title":"J Clin Oncol"},{"key":"2226_CR38","doi-asserted-by":"crossref","first-page":"11837","DOI":"10.1073\/pnas.93.21.11837","volume":"93","author":"S Stilgenbauer","year":"1996","unstructured":"Stilgenbauer S, Liebisch P, James MR, Schroder M, Schlegelberger B, Fischer K, Bentz M, et al. Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders. Proc Natl Acad Sci USA. 1996;93:11837\u201341.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 1","key":"2226_CR39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/annonc\/11.suppl_1.S127","volume":"11","author":"S Stilgenbauer","year":"2000","unstructured":"Stilgenbauer S, Schaffner C, Winkler D, Ott G, Leupolt E, Bentz M, Moller P, et al. The ATM gene in the pathogenesis of mantle-cell lymphoma. Ann Oncol. 2000;11(Suppl 1):127\u201330.","journal-title":"Ann Oncol"},{"key":"2226_CR40","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1073\/pnas.0831102100","volume":"100","author":"NY Fang","year":"2003","unstructured":"Fang NY, Greiner TC, Weisenburger DD, Chan WC, Vose JM, Smith LM, Armitage JO, et al. Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma. Proc Natl Acad Sci USA. 2003;100:5372\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2226_CR41","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1073\/pnas.0510441103","volume":"103","author":"TC Greiner","year":"2006","unstructured":"Greiner TC, Dasgupta C, Ho VV, Weisenburger DD, Smith LM, Lynch JC, Vose JM, et al. Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma. Proc Natl Acad Sci USA. 2006;103:2352\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2226_CR42","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1182\/blood-2002-02-0382","volume":"100","author":"K Gronbaek","year":"2002","unstructured":"Gronbaek K, Worm J, Ralfkiaer E, Ahrenkiel V, Hokland P, Guldberg P. ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma. Blood. 2002;100:1430\u20137.","journal-title":"Blood"},{"key":"2226_CR43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cell.2004.06.023","volume":"118","author":"CJ Bakkenist","year":"2004","unstructured":"Bakkenist CJ, Kastan MB. Initiating cellular stress responses. Cell. 2004;118:9\u201317.","journal-title":"Cell"},{"key":"2226_CR44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nature05268","volume":"444","author":"J Bartkova","year":"2006","unstructured":"Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature. 2006;444:633\u20137.","journal-title":"Nature"},{"key":"2226_CR45","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nature03482","volume":"434","author":"J Bartkova","year":"2005","unstructured":"Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005;434:864\u201370.","journal-title":"Nature"},{"key":"2226_CR46","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nature03485","volume":"434","author":"VG Gorgoulis","year":"2005","unstructured":"Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature. 2005;434:907\u201313.","journal-title":"Nature"},{"key":"2226_CR47","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1038\/sj.leu.2404748","volume":"21","author":"S Horibe","year":"2007","unstructured":"Horibe S, Takagi M, Unno J, Nagasawa M, Morio T, Arai A, Miura O, et al. DNA damage check points prevent leukemic transformation in myelodysplastic syndrome. Leukemia. 2007;21:2195\u20138.","journal-title":"Leukemia"},{"key":"2226_CR48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11899-007-0010-6","volume":"2","author":"T Skorski","year":"2007","unstructured":"Skorski T. Genomic instability: the cause and effect of BCR\/ABL tyrosine kinase. Curr Hematol Malig Rep. 2007;2:69\u201374.","journal-title":"Curr Hematol Malig Rep"},{"key":"2226_CR49","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s11033-009-9730-0","volume":"37","author":"T Poplawski","year":"2010","unstructured":"Poplawski T, Blasiak J. BCR\/ABL downregulates DNA-PK(CS)-dependent and upregulates backup non-homologous end joining in leukemic cells. Mol Biol Rep. 2010;37:2309\u201315.","journal-title":"Mol Biol Rep"},{"key":"2226_CR50","doi-asserted-by":"crossref","first-page":"e15525","DOI":"10.1371\/journal.pone.0015525","volume":"5","author":"A Valeri","year":"2010","unstructured":"Valeri A, Alonso-Ferrero ME, Rio P, Pujol MR, Casado JA, Perez L, Jacome A, et al. Bcr\/Abl interferes with the Fanconi anemia\/BRCA pathway: implications in the chromosomal instability of chronic myeloid leukemia cells. PLoS One. 2010;5:e15525.","journal-title":"PLoS One"},{"key":"2226_CR51","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1182\/blood-2002-10-3011","volume":"101","author":"E Deutsch","year":"2003","unstructured":"Deutsch E, Jarrousse S, Buet D, Dugray A, Bonnet ML, Vozenin-Brotons MC, Guilhot F, et al. Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cells. Blood. 2003;101:4583\u20138.","journal-title":"Blood"},{"key":"2226_CR52","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1038\/leu.2009.164","volume":"23","author":"A Slupianek","year":"2009","unstructured":"Slupianek A, Jozwiakowski SK, Gurdek E, Skorski T. BCR\/ABL kinase interacts with and phosphorylates the RAD51 paralog, RAD51B. Leukemia. 2009;23:2308\u201310.","journal-title":"Leukemia"},{"key":"2226_CR53","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1097-2765(01)00357-4","volume":"8","author":"A Slupianek","year":"2001","unstructured":"Slupianek A, Schmutte C, Tombline G, Nieborowska-Skorska M, Hoser G, Nowicki MO, Pierce AJ, et al. BCR\/ABL regulates mammalian RecA homologs, resulting in drug resistance. Mol Cell. 2001;8:795\u2013806.","journal-title":"Mol Cell"},{"key":"2226_CR54","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.dnarep.2013.04.022","volume":"12","author":"M Takagi","year":"2013","unstructured":"Takagi M, Sato M, Piao J, Miyamoto S, Isoda T, Kitagawa M, Honda H, et al. ATM-dependent DNA damage-response pathway as a determinant in chronic myelogenous leukemia. DNA Repair (Amst). 2013;12:500\u20137.","journal-title":"DNA Repair (Amst)"},{"key":"2226_CR55","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1349-7006.2007.00567.x","volume":"98","author":"M Miwa","year":"2007","unstructured":"Miwa M, Masutani M. PolyADP-ribosylation and cancer. Cancer Sci. 2007;98:1528\u201335.","journal-title":"Cancer Sci"},{"key":"2226_CR56","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/356356a0","volume":"356","author":"MS Satoh","year":"1992","unstructured":"Satoh MS, Lindahl T. Role of poly(ADP-ribose) formation in DNA repair. Nature. 1992;356:356\u20138.","journal-title":"Nature"},{"key":"2226_CR57","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc2342","volume":"8","author":"T Helleday","year":"2008","unstructured":"Helleday T, Petermann E, Lundin C, Hodgson B, Sharma RA. DNA repair pathways as targets for cancer therapy. Nat Rev Cancer. 2008;8:193\u2013204.","journal-title":"Nat Rev Cancer"},{"key":"2226_CR58","doi-asserted-by":"crossref","first-page":"55117","DOI":"10.1074\/jbc.M404524200","volume":"279","author":"M Audebert","year":"2004","unstructured":"Audebert M, Salles B, Calsou P. Involvement of poly(ADP-ribose) polymerase-1 and XRCC1\/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J Biol Chem. 2004;279:55117\u201326.","journal-title":"J Biol Chem"},{"key":"2226_CR59","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1093\/nar\/gkg761","volume":"31","author":"SF El-Khamisy","year":"2003","unstructured":"El-Khamisy SF, Masutani M, Suzuki H, Caldecott KW. A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage. Nucleic Acids Res. 2003;31:5526\u201333.","journal-title":"Nucleic Acids Res"},{"key":"2226_CR60","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature03443","volume":"434","author":"HE Bryant","year":"2005","unstructured":"Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature. 2005;434:913\u20137.","journal-title":"Nature"},{"key":"2226_CR61","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature. 2005;434:917\u201321.","journal-title":"Nature"},{"key":"2226_CR62","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3324\/haematol.2008.001933","volume":"94","author":"TJ Gaymes","year":"2009","unstructured":"Gaymes TJ, Shall S, MacPherson LJ, Twine NA, Lea NC, Farzaneh F, Mufti GJ. Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes. Haematologica. 2009;94:638\u201346.","journal-title":"Haematologica"},{"key":"2226_CR63","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1158\/1535-7163.MCT-09-0142","volume":"8","author":"TM Horton","year":"2009","unstructured":"Horton TM, Jenkins G, Pati D, Zhang L, Dolan ME, Ribes-Zamora A, Bertuch AA, et al. Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity. Mol Cancer Ther. 2009;8:2232\u201342.","journal-title":"Mol Cancer Ther"},{"key":"2226_CR64","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nm.3993","volume":"21","author":"MT Esposito","year":"2015","unstructured":"Esposito MT, Zhao L, Fung TK, Rane JK, Wilson A, Martin N, Gil J, et al. Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors. Nat Med. 2015;21:1481\u201390.","journal-title":"Nat Med"},{"key":"2226_CR65","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.bbadis.2014.12.001","volume":"1852","author":"I Faraoni","year":"2015","unstructured":"Faraoni I, Compagnone M, Lavorgna S, Angelini DF, Cencioni MT, Piras E, Panetta P, et al. BRCA1, PARP1 and gammaH2AX in acute myeloid leukemia: role as biomarkers of response to the PARP inhibitor olaparib. Biochim Biophys Acta. 2015;1852:462\u201372.","journal-title":"Biochim Biophys Acta"},{"key":"2226_CR66","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.canlet.2016.11.021","volume":"386","author":"J Piao","year":"2017","unstructured":"Piao J, Takai S, Kamiya T, Inukai T, Sugita K, Ohyashiki K, Delia D, et al. Poly (ADP-ribose) polymerase inhibitors selectively induce cytotoxicity in TCF3-HLF-positive leukemic cells. Cancer Lett. 2017;386:131\u201340.","journal-title":"Cancer Lett"}],"updated-by":[{"DOI":"10.1007\/s12185-017-2298-x","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T00:00:00Z","timestamp":1499644800000}}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-017-2226-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-017-2226-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-017-2226-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T04:37:14Z","timestamp":1658896634000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-017-2226-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,3]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["2226"],"URL":"https:\/\/doi.org\/10.1007\/s12185-017-2226-0","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/s12185-017-2298-x","asserted-by":"object"}]},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,3]]}}}